FDA Should Design AF Trials To Remove Sponsor Guesswork – HRS’ Calkins

The Heart Rhythm Society should work with FDA to develop detailed sample trial designs for atrial fibrillation ablation devices, according to Hugh Calkins, HRS trustee and director of electrophysiology at Johns Hopkins University